Department of Pediatrics, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States.
Department of Microbiology and Immunology, University of Rochester School of Medicine and Dentistry, Rochester, NY, United States.
Front Immunol. 2018 Sep 19;9:2131. doi: 10.3389/fimmu.2018.02131. eCollection 2018.
Invasive fungal infections, including Pneumonia (PcP), remain frequent life-threatening conditions of patients with adaptive immune defects. While innate immunity helps control pathogen growth early during infection, it is typically not sufficient for complete protection against and other human fungal pathogens. Alveolar macrophages (AM) possess pattern recognition molecules capable of recognizing antigenic and structural determinants of . However, this pathogen effectively evades innate immunity to infect both immunocompetent and immunosuppressed hosts, albeit with differing outcomes. During our studies of mouse models of PcP, the FVB/N strain was identified as unique because of its ability to mount a protective innate immune response against infection. In contrast to other immunocompetent strains, which become transiently infected prior to the onset of adaptive immunity, FVB/N mice rapidly eradicated before an adaptive immune response was triggered. Furthermore, FVB/N mice remained highly resistant to infection even in the absence of functional T cells. The effector mechanism of innate protection required the action of functional alveolar macrophages, and the adoptive transfer of resistant FVB/N AMs, but not susceptible CB.17 AMs, conferred protection to immunodeficient mice. Macrophage IFNγ receptor signaling was not required for innate resistance, and FVB/N macrophages were found to display markers of alternative activation. IFNγ reprogrammed resistant FVB/N macrophages to a permissive M1 biased phenotype through a mechanism that required direct activation of the macrophage IFNγR. These results demonstrate that appropriately programmed macrophages provide protective innate immunity against this opportunistic fungal pathogen, and suggest that modulating macrophage function may represent a feasible therapeutic strategy to enhance antifungal host defense. The identification of resistant and susceptible macrophages provides a novel platform to study not only the mechanisms of macrophage-mediated antifungal defense, but also the mechanisms by which evades innate immunity.
侵袭性真菌感染,包括肺炎(PcP),仍然是适应性免疫缺陷患者频繁发生的危及生命的疾病。虽然先天免疫有助于在感染早期控制病原体的生长,但它通常不足以完全防止和其他人类真菌病原体的感染。肺泡巨噬细胞(AM)具有能够识别的抗原和结构决定簇的模式识别分子。然而,这种病原体有效地逃避先天免疫,感染免疫功能正常和免疫抑制的宿主,尽管结果不同。在我们对 PcP 小鼠模型的研究中,FVB/N 品系因其能够对感染产生保护性先天免疫反应而被鉴定为独特品系。与其他免疫功能正常的菌株不同,这些菌株在适应性免疫开始之前会短暂感染,而 FVB/N 小鼠在触发适应性免疫反应之前迅速清除了。此外,即使没有功能性 T 细胞,FVB/N 小鼠仍然对感染具有高度抗性。先天保护的效应机制需要功能性肺泡巨噬细胞的作用,以及抵抗 FVB/N AM 的过继转移,但不抵抗易感 CB.17 AM,赋予免疫缺陷小鼠保护作用。巨噬细胞 IFNγ 受体信号传导不是先天抵抗所必需的,并且发现 FVB/N 巨噬细胞显示出替代激活的标记。IFNγ 通过一种需要直接激活巨噬细胞 IFNγR 的机制将抵抗 FVB/N 巨噬细胞重新编程为允许的 M1 偏向表型。这些结果表明,适当编程的巨噬细胞提供了针对这种机会性真菌病原体的保护性先天免疫,并表明调节巨噬细胞功能可能代表增强抗真菌宿主防御的可行治疗策略。抵抗和易感巨噬细胞的鉴定为研究不仅提供了一种新的平台,研究巨噬细胞介导的抗真菌防御的机制,还研究了逃避先天免疫的机制。